Apple's Jobs Makes Info About His Health A Trade Secret
It would be easier to gauge Apple CEO Steve Jobs' current medical problems if he had said more about the ones he has faced in the past.
Watch CBS News
It would be easier to gauge Apple CEO Steve Jobs' current medical problems if he had said more about the ones he has faced in the past.
There is some new hope in treating an aggressive form of breast cancer.
Blue Shield of California is planning to go forward with scheduled health insurance rate increases despite calls from government regulators to delay the move.
Researchers suggested, though, that there were simple things that could reduce a woman's exposure.
Seven San Francisco middle school students who were briefly hospitalized Thursday after coming into contact with rat poison they mistook for candy are now okay.
Seven San Francisco middle school students were taken to hospitals Thursday after apparently mistaking rat poison for candy, according to authorities.
It's being called an aggressive step in fighting the nation's childhood obesity epidemic: new federal guidelines that will cut the "junk" out of our school cafeterias.
A new study suggests on how all that sweet stuff may boost the risk of heart disease in teenagers.
Frontman Roger Daltrey of The Who doesn't consider himself a legend but many people do. But his world came to a standstill when his voice was almost taken away.
The Mt. Diablo school board has approved nearly $1 million in funding to cover mental health costs that were vetoed in the last state budget.
A much anticipated report from the California Council on Science and Technology confirms no significant health impacts from SmartMeters, but some remain skeptical.
Baby Emma and her three sisters, Audrey, Natalie and Isabelle are getting healthier by the day.
California is about to become the first state in the nation to regulate how long it should take patients to get a doctor's appointment, or at least an evaluation.
California's top prosecutor is calling on the U.S. Supreme Court to bar drug companies from making agreements with competitors to keep quiet about generic versions of their brand name drugs.
